Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in severe steroid-dependent asthma
2015-001573-40Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Dupixent with Placebo (2 arms). Primary endpoint: Percentage reduction in oral corticosteroid dose while maintaining asthma control. Started Aug 2015; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-001573-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001573-40.